Abiopharma

🔍 Ghei Ashima (Executive)

Company: BROADRIDGE FINANCIAL SOLUTIONS, INC. (BR)

Report Date: 2026-06-27

Detailed Transactions and Holdings:

• Acquired 2,509 shares of Common Stock (Direct)
  Date: 2026-06-27 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,466.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 905 shares of Common Stock at $137.93 per share (Direct)
  Date: 2026-06-27 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,561.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 2,509 shares of FY2024 RSUs June 2024 (Derivative)
  Date: 2026-06-27 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1

Footnotes:

• F1: Each Restricted Stock Unit represented one share of Broadridge common stock and on June 27, 2026 2,509 Restricted Stock Units vested and converted into an equal number of shares of common stock.
• F2: Represents the amount of shares withheld to cover tax liabilities upon the vesting of 2,509 Restricted Stock Units that vested and converted into an equal number of shares of common stock on June 27, 2026.